Balsm Alofoq Medical Co (SAU:9620) ROCE %: 6.77% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SAU:9620 Balsm Alofoq Medical Co SAU:9620
24 GF Score
Price ﷼24.70
! 4 Warning Signs
View Full Analysis

What is Balsm Alofoq Medical Co ROCE %?

Balsm Alofoq Medical Co SAU:9620 24 ROCE % is 6.77% as of Dec. 2025. GuruFocus rates SAU:9620 with a GF Score™ of 24/100. The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Balsm Alofoq Medical Co's annualized ROCE % for the quarter that ended in Dec. 2025 was 6.77%.

Balsm Alofoq Medical Co  (SAU:9620) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Balsm Alofoq Medical Co ROCE % Related Terms

Balsm Alofoq Medical Co ROCE % Historical Data

* Premium members only.

The historical data trend for Balsm Alofoq Medical Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Balsm Alofoq Medical Co ROCE % Chart

Balsm Alofoq Medical Co Annual Data
Trend Dec23 Dec24 Dec25
ROCE %
25.67 21.19 7.94

Balsm Alofoq Medical Co Semi-Annual Data
Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % 0.00 17.74 23.05 9.05 6.77
SAU:9620
24GF Score
Balsm Alofoq Medical Co SAU:9620
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Balsm Alofoq Medical Co ROCE % Calculation

Balsm Alofoq Medical Co's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=2.591/( ( (33.279 - 1.639) + (35.649 - 2.008) )/ 2 )
=2.591/( (31.64+33.641)/ 2 )
=2.591/32.6405
=7.94 %

Balsm Alofoq Medical Co's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=2.256/( ( (34.331 - 1.278) + (35.649 - 2.008) )/ 2 )
=2.256/( ( 33.053 + 33.641 )/ 2 )
=2.256/33.347
=6.77 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 6.77% mean?
Balsm Alofoq Medical Co (SAU:9620) has a ROCE % of 6.77% as of Dec. 2025.
Is Balsm Alofoq Medical Co's ROCE % too high?
Balsm Alofoq Medical Co's current ROCE % is 6.77%. The Medical Devices & Instruments industry median ROCE % is 2.30. Balsm Alofoq Medical Co's value of 6.77% is 195% above this industry median. Overall, Balsm Alofoq Medical Co has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Balsm Alofoq Medical Co's ROCE % compare to ABT and SYK?
Balsm Alofoq Medical Co's ROCE % of 6.77% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.30. Balsm Alofoq Medical Co's value of 6.77% is 195% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.30, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Balsm Alofoq Medical Co's current ROCE % of 6.77% is 195% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Balsm Alofoq Medical Co's current ROCE % is 6.77%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Balsm Alofoq Medical Co stock overvalued right now?
Balsm Alofoq Medical Co (SAU:9620) has a current ROCE % of 6.77%. The current ROCE % is 6.77% and 195% above the Medical Devices & Instruments industry median of 2.30. Balsm Alofoq Medical Co's overall GF Score™ is 24/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Balsm Alofoq Medical Co (SAU:9620), the current ROCE % is 6.77% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Balsm Alofoq Medical Co Business Description

Address King Khalid Road, Qassim Region, Al-Ufuq District, Buraidah, SAU
Balsm Alofoq Medical Co operates in the medical sector. Its activities include medical services, specialized clinics and medical complexes, medical operations, and the import and supply of medical devices and supplies to all regions of the Kingdom of Saudi Arabia.
24GF Score

Get the complete analysis for SAU:9620

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

﷼24.70
Price